"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 |
| 1996 | 2 | 0 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 5 | 0 | 5 |
| 2001 | 2 | 0 | 2 |
| 2002 | 3 | 1 | 4 |
| 2003 | 6 | 3 | 9 |
| 2004 | 2 | 0 | 2 |
| 2005 | 4 | 0 | 4 |
| 2006 | 3 | 1 | 4 |
| 2007 | 5 | 0 | 5 |
| 2008 | 8 | 2 | 10 |
| 2009 | 4 | 3 | 7 |
| 2010 | 6 | 0 | 6 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 5 | 3 | 8 |
| 2014 | 4 | 2 | 6 |
| 2015 | 11 | 2 | 13 |
| 2016 | 5 | 4 | 9 |
| 2017 | 11 | 1 | 12 |
| 2018 | 5 | 5 | 10 |
| 2019 | 8 | 1 | 9 |
| 2020 | 12 | 1 | 13 |
| 2021 | 16 | 0 | 16 |
| 2022 | 12 | 0 | 12 |
| 2023 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e009905.
-
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials. Nephrol Dial Transplant. 2023 07 31; 38(8):1890-1897.
-
Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30564.
-
Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy. Front Immunol. 2023; 14:1155778.
-
Emotional distress predicts palliative cancer care attitudes: The unique role of anger. Psychooncology. 2023 05; 32(5):692-700.
-
Subsets of Idiopathic Inflammatory Myositis Enriched for Contemporaneous Cancer Relative to the General Population. Arthritis Rheumatol. 2023 04; 75(4):620-629.
-
Variability in COVID-19 Vaccine Response Among People With Cancer: What Health Care Strategy Best Protects the Vulnerable? JAMA Oncol. 2023 02 01; 9(2):177-179.
-
Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department? J Emerg Med. 2023 Jan; 64(1):111-118.
-
Adolescent and young adult cancers: unmet needs and closing the gaps. Curr Opin Pediatr. 2023 02 01; 35(1):84-90.
-
Creation of a quality improvement collaborative to address adolescent and young adult cancer clinical trial enrollment: ATAQI (AYA trial access quality initiative). Curr Probl Cancer. 2023 Dec; 47(6):100898.